Founded by a team of experienced pharmaceutical industry professionals and biotech entrepreneurs based in Oxford, UK, the company is founded upon a deep understanding of the human biology of GPR35. We are developing small-molecule inhibitors for the treatment of ulcerative colitis and other GI diseases.
Company Details
- Employees
- 15
- Address
- 99 Park Drive, Milton, Abingdon, England, Ox14 4ry, Milton,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://30fivebio.com
- HQ
- Milton
Thirtyfivebio Questions
Thirtyfivebio's website is http://30fivebio.com
Thirtyfivebio's LinkedIn profile is https://uk.linkedin.com/company/thirtyfivebio
Thirtyfivebio has
15 employees.
View email and phone details for 15
employees at Thirtyfivebio.
Thirtyfivebio's industry is
Biotechnology Research
Thirtyfivebio's top competitors are
Molecule To Medicine,
Lucia Bio,
Sygnature Discovery,
Outrun Therapeutics,
Nuage Therapeutics,
Enara Bio,
Melio Bio,
Pathios Therapeutics,
Greywolf Therapeutics,
Theolytics.
Thirtyfivebio's categories are Biotechnology Research
